Fig. 2From: Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participantsFreedom from triple endpoint according to induction regimen. Basi, basiliximab; rATG, rabbit antithymocyte globulinBack to article page